GleamWall
中文EN

VASO VASO Corp

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 839087 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.2%
TTM net income YoY-5.0%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-5.9%
Net income 3-yr CAGR-40.6%

Margins

Gross margin68.2%
Operating margin-3.7%
Net margin3.6%
FCF margin—
EBITDA margin-2.3%

Returns

ROE8.3%
ROA2.9%
ROIC (approx.)—
Asset turnover0.82x

Leverage & solvency

Liabilities / assets62.8%
Debt / equity0.00x
Current ratio2.25x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.77x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$10.79M$11.19M$19.36M$27.02M$12.38M$10.33M$19.46M$27.04M
Cost of revenue$2.22M$2.30M$7.78M$9.40M$2.83M$2.39M$8.10M$9.81M
Gross profit$8.56M$8.89M$11.58M$17.62M$9.55M$7.94M$11.36M$17.23M
R&D expense$236,000$212,000$183,000$237,000$146,000$167,000$178,000$264,000
SG&A expense$7.70M$7.70M$12.72M$28.42M$8.02M$7.68M$12.40M$14.67M
Operating income$632,000$974,000-$1.33M-$2.79M$1.38M$93,000-$1.22M$2.15M
Interest expense———————$0
Pretax income$931,000$1.23M-$1.07M-$2.80M$1.58M$351,000-$1.03M$2.32M
Income tax$363,000$387,000-$188,000-$2.99M$25,000$28,000$40,000$172,000
Net income$1.67M$544,000-$887,000$1.13M$1.71M-$197,000-$1.07M$2.15M
EBITDA$796,000$1.20M-$1.09M-$2.46M$1.56M$285,000-$1.06M$2.35M
EPS (basic)0.010.00-0.01—0.010.00-0.01—
EPS (diluted)0.010.00-0.01—0.010.00-0.01—
Weighted avg. shares (diluted)176.37M176.34M175,953—175.92M175.74M175,696—
Balance sheet
Cash & equivalents$49.95M$38.29M$21.97M$34.08M$34.86M$32.56M$25.31M$26.27M
Receivables————$1.10M$1.09M$1.06M$916,000
Inventory$812,000$837,000$827,000$833,000$893,000$939,000$965,000$911,000
Current assets$65.57M$55.19M$51.14M$58.56M$51.91M$49.97M$45.98M$51.19M
PP&E, net$89,000$101,000$1.25M$121,000$1.41M$1.85M$1.59M$1.54M
Goodwill$1.28M$1.26M$10.98M$1.23M$15.58M$15.57M$15.56M$1.18M
Intangibles$1.89M$1.72M$2.17M$1.25M$1.86M$1.82M$1.77M$1.61M
Total assets$83.00M$85.91M$82.98M$89.32M$84.47M$82.58M$77.91M$82.94M
Current liabilities$29.19M$32.86M$30.56M$36.85M$31.60M$33.02M$30.25M$34.72M
Total liabilities$52.09M$56.70M$54.38M$59.89M$56.24M$56.08M$51.26M$55.24M
Shareholders' equity$30.91M$29.21M$28.60M$29.43M$28.24M$26.50M$26.65M$27.70M
Shares outstanding176.24M176.02M175.95M175.95M175.95M175.75M175.70M175.70M
Cash flow statement
Operating cash flow$1.72M$17.44M-$12.62M$261,000$2.78M$6.79M-$566,000-$367,000
Capital expenditure$298,000$504,000$459,000—-$225,000$504,000$363,000—
Free cash flow$1.42M$16.94M-$13.08M—$3.01M$6.29M-$929,000—
Investing cash flow$12.51M-$504,000-$459,000-$83,000$225,000-$504,000-$363,000-$223,000
Financing cash flow-$169,000——$2,000-$690,000$963,000-$27,000-$22,000
Depreciation & amortization$164,000$229,000$243,000$327,000$179,000$192,000$160,000$194,000
Stock-based compensation$28,000$11,000$8,000$8,000$8,000$9,000$8,000$28,000

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.